{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:58:40Z","timestamp":1785830320051,"version":"3.56.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Amyloidosis is characterized by a disorder of protein conformation and metabolism, resulting in deposits of insoluble fibrils in various organs causing functional disturbances. Amyloidosis can also affect the heart. Cardiac amyloidosis tends to have a poor prognostic outcome if diagnosed at a late stage. Therefore, early diagnosis and initiation of therapy as well as monitoring of treatment response are crucial to improve outcomes and to learn more about its pathophysiology and clinical course. We present an 83-year-old woman with cardiac transthyretin amyloidosis (ATTR) who was treated with tafamidis. The patient significantly improved 18 months after initiation of therapy with regards to exercise capacity and quality of life. In addition to standard diagnostic methods, we used magnetocardiography (MCG) to monitor potential treatment response by detecting changes in the magnetic field of the heart. MCG is a non-invasive method that detects the cardiac magnetic field generated by electrical currents in the heart with high sensitivity. We have recently shown that this magnetic field changes in various types of cardiomyopathies may be used as a non-invasive screening tool. We determined previously that an MCG vector \u22650.052 was the optimal threshold to detect cardiac amyloidosis. The patient's MCG was measured at various time points during therapy. At the time of diagnosis, the patient's MCG vector was 0.052. After starting therapy, the MCG vector increased to 0.090, but improved to 0.037 after 4 months of therapy. The MCG vector reached a value of 0.017 after 5 months of therapy with tafamidis, and then increased slightly after 27 months to a value of 0.027 (&amp;lt;0.052). Data from this case support our previous findings that MCG may be used to monitor treatment response non-invasively. Further research is needed to understand the unexpected changes in the MCG vector that were observed at the beginning of therapy and later in the course. Larger studies will be necessary to determine how these changes in the electromagnetic field of the heart are related to structural changes and how they affect clinical outcomes.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1224578","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T21:44:27Z","timestamp":1692308667000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Case report: Magnetocardiography as a potential method of therapy monitoring in amyloidosis"],"prefix":"10.3389","volume":"10","author":[{"given":"Ainoosh","family":"Golpour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Suwalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Landmesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Heidecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3949\/ccjm.84.s3.02","article-title":"Cardiac amyloidosis: an update on diagnosis and treatment","volume":"84","author":"Donnelly","year":"2017","journal-title":"Cleve Clin J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (light-chain) cardiac amyloidosis: a review of diagnosis and therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1182\/blood-2016-06-721878","article-title":"The prognostic value of multiparametric flow cytometry in AL amyloidosis at diagnosis and at the end of first-line treatment","volume":"129","author":"Muchtar","year":"2017","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11864-020-00738-8","article-title":"Advances in the treatment of cardiac amyloidosis","volume":"21","author":"Macedo","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/ejhf.1695","article-title":"Emerging therapies in transthyretin amyloidosis\u2013a new wave of hope after years of stagnancy?","volume":"22","author":"M\u00fcller","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/ejhf.2641","article-title":"Transthyretin amyloidosis: the picture is getting clearer","volume":"24","author":"Musigk","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14797\/mdcvj.1050","article-title":"Cardiac amyloidosis treatment","volume":"18","author":"Stern","year":"2022","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-8-74","article-title":"Synergy of combined doxycycline\/TUDCA treatment in lowering transthyretin deposition and associated biomarkers: studies in FAP mouse models","volume":"8","author":"Cardoso","year":"2010","journal-title":"J Transl Med"},{"key":"B13","first-page":"19","article-title":"Cardiac amyloidosis: epidemiology, diagnosis and therapy","volume":"19","author":"Papingiotis","year":"2021","journal-title":"e-J Cardiol Pract"},{"key":"B14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.carpath.2015.07.008","article-title":"Cardiac amyloidosis: pathology, nomenclature, and typing","volume":"24","author":"Maleszewski","year":"2015","journal-title":"Cardiovasc Pathol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/hrt.74.5.541","article-title":"Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation","volume":"74","author":"Dubrey","year":"1995","journal-title":"Heart"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1161\/CIRCULATIONAHA.107.697763","article-title":"Intracardiac thrombosis and embolism in patients with cardiac amyloidosis","volume":"116","author":"Feng","year":"2007","journal-title":"Circulation"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1161\/CIRCULATIONAHA.108.785014","article-title":"Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis","volume":"119","author":"Feng","year":"2009","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e027619","DOI":"10.1161\/JAHA.122.027619","article-title":"Application of magnetocardiography to screen for inflammatory cardiomyopathy and monitor treatment response","volume":"12","author":"Brala","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1515\/bmte.1989.34.s1.205","article-title":"Magnetocardiography: technical progress by a multichannel SQUID system","volume":"34","author":"Moshage","year":"1989","journal-title":"Biomed Tech"},{"key":"B20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0002-8703(63)90075-9","article-title":"Detection of the magnetic field of the heart","volume":"66","author":"Baule","year":"1963","journal-title":"Am Heart J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/ejhf.2027","article-title":"Efficacy and safety of tafamidis doses in the tafamidis in transthyretin cardiomyopathy clinical trial (ATTR-ACT) and long-term extension study","volume":"23","author":"Damy","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B23","article-title":"Practice: detection of myocardial damage in CAD patients and in patients recovered from COVID-19","volume-title":"IntechOpen [Internet]","author":"Chaikovsky","year":"2022"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e005407","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407","article-title":"Epidemiology of cardiac amyloidosis\u2013associated heart failure hospitalizations among fee-for-service medicare beneficiaries in the United States","volume":"12","author":"Gilstrap","year":"2019","journal-title":"Circ Heart Fail"},{"key":"B25","first-page":"III-743","article-title":"Resting magnetocardiography accurately detects myocardial ischemia in chest pain patients with normal or non-specific ECG findings","volume":"200","author":"Tolstrup","year":"2004","journal-title":"Circulation"},{"key":"B26","doi-asserted-by":"publisher","first-page":"A149","DOI":"10.1016\/S0735-1097(04)90634-1","article-title":"874-2 Reproducibility and interpretation of magneto-cardio-gram maps in detecting ischemia","volume":"43","author":"Steinberg","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00132577-200212000-00029","article-title":"Sensitivity and predictivity of magnetocardiography for the diagnosis of ischemic heart disease in patients with acute chest pain: preliminary results of the hoyerswerda registry study","volume":"1","author":"Park","year":"2002","journal-title":"Crit Pathw Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1515\/BMT.2004.050","article-title":"Qualitative and quantitative description of myocardial ischemia by means of magnetocardiography","volume":"49","author":"Park","year":"2004","journal-title":"Biomed Tech"},{"key":"B29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/00019501-200405000-00004","article-title":"Myocardial viability evaluation using magnetocardiography in patients with coronary artery disease","volume":"15","author":"Morguet","year":"2004","journal-title":"Coron Artery Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF03042399","article-title":"Die bedeutung der magnetokardiographie bei koronarer herzerkrankung und myokardinfarkt","volume":"8","author":"Hailer","year":"1997","journal-title":"Herzschrittmacherther Elektrophysiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/MCA.0000000000000107","article-title":"Predictive value of the complex magnetocardiographic index in patients with intermediate pretest probability of chronic coronary artery disease: results of a two-center study","volume":"25","author":"Chaikovsky","year":"2014","journal-title":"Coron Artery Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/eurheartj\/14.suppl_E.46","article-title":"Magnetocardiography: supraventricular arrhythmias and preexcitation syndromes","volume":"14","author":"M\u00e4kij\u00e4rvi","year":"1993","journal-title":"Eur Heart J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1111\/j.1471-0528.1999.tb08149.x","article-title":"Magnetocardiography in the diagnosis of fetal arrhythmia","volume":"106","author":"Van Leeuwen","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/S0002-9149(01)01658-7","article-title":"Usefulness of magnetocardiography for the investigation of fetal arrhythmias","volume":"88","author":"Men\u00e9ndez","year":"2001","journal-title":"Am J Cardiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1540-8167.1997.tb01824.x","article-title":"Magnetocardiography and 32-lead potential mapping: repolarization in normal subjects during pharmacologically induced stress","volume":"8","author":"Brockmeier","year":"1997","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B36","first-page":"147","article-title":"Detection of exercise induced myocardial ischemia by multichannel magnetocardiography in single vessel coronary disease","volume-title":"Ann Noninvasive Electrocardiol","author":"H\u00e4nninen","year":"2000"},{"key":"B37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s003950170049","article-title":"Recording locations in multichannel magnetocardiography and body surface potential mapping sensitive for regional exercise-induced myocardial ischemia","volume":"96","author":"H\u00e4nninen","year":"2001","journal-title":"Basic Res Cardiol"},{"key":"B38","first-page":"14","article-title":"Non-invasive electrophysiologic study with amagnetic transesophageal pacing during unshielded multichannel magnetocardiographic mapping","volume":"30","author":"Fenici","year":"2004","journal-title":"Neurol Clin Neurophysiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0022-0736(97)80041-6","article-title":"High-pass-filtered magnetocardiogram and cardiomyopathy in patients with type 1 diabetes mellitus","volume":"30","author":"Brockmeier","year":"1997","journal-title":"J Electrocardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1046\/j.1540-8167.2001.00772.x","article-title":"Repolarization abnormalities detected by magnetocardiography in patients with dilated cardiomyopathy and ventricular arrhythmias","volume":"12","author":"Korhonen","year":"2001","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0022-0736(84)80058-8","article-title":"Magnetocardiograms of patients with left ventricular overloading recorded with a second-derivative SQUID gradiometer","volume":"17","author":"Fujino","year":"1984","journal-title":"J Electrocardiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/00004872-200211000-00029","article-title":"Magnetocardiographic indices of left ventricular hypertrophy","volume":"20","author":"Karvonen","year":"2002","journal-title":"J Hypertens"},{"key":"B43","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1540-8159.2004.00518.x","article-title":"Concentric remodeling detection by magnetocardiography in patients with recent onset arterial hypertension","volume":"27","author":"Comani","year":"2004","journal-title":"Pacing Clin Electrophysiol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"779800","DOI":"10.3389\/fmedt.2021.779800","article-title":"Multistage classification of current density distribution maps of various heart states based on correlation analysis and k-NN algorithm","volume":"3","author":"Udovychenko","year":"2021","journal-title":"Front Med Technol"},{"key":"B45","author":"Fainzilberg","year":"2007"},{"key":"B46","author":"Chaikovsky","year":"2000"},{"key":"B47","first-page":"555","author":"Schmitz","year":"1992"},{"key":"B48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4236\/wjcd.2013.35059","article-title":"Magnetocardiography capabilities in myocardium injuries diagnosis","volume":"3","author":"Sosnytskyy","year":"2013","journal-title":"World J Cardiovasc Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF01797748","article-title":"Clinical magnetocardiography: 10 years experience at the Catholic University","volume":"7","author":"Fenici","year":"1991","journal-title":"Int J Cardiovasc Imaging"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/ejhf.2669","article-title":"Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the heart failure association of the European society of cardiology (ESC) and the ESC working group on myocardial and pericardial diseases","volume":"24","author":"Heidecker","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B51","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1540-8167.2000.tb00168.x","article-title":"Recovery time dispersion measured from 87-lead body surface potential mapping as a predictor of sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy","volume":"11","author":"Aiba","year":"2000","journal-title":"J Cardiovasc Electrophysiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"103895","DOI":"10.1016\/j.compbiomed.2020.103895","article-title":"A computational investigation into rate-dependant vectorcardiogram changes due to specific fibrosis patterns in non-isch\u00e6mic dilated cardiomyopathy","volume":"123","author":"Gemmell","year":"2020","journal-title":"Comput Biol Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"C179","DOI":"10.1093\/eurheartjsupp\/suad043","article-title":"The electrocardiogram in non-ischaemic-dilated cardiomyopathy","volume":"25","author":"Crescenzi","year":"2023","journal-title":"Eur Heart J Suppl"},{"key":"B54","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.hrthm.2009.09.065","article-title":"Fragmented QRS on twelve-lead electrocardiogram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy","volume":"7","author":"Das","year":"2010","journal-title":"Heart Rhythm"},{"key":"B55","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/oxfordjournals.eurheartj.a060289","article-title":"Significance of ventricular late potentials in non-ischaemic dilated cardiomyopathy","volume":"13","author":"D\u00e9n\u00e9r\u00e9az","year":"1992","journal-title":"Eur Heart J"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/ehjci\/jew298","article-title":"Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis","volume":"18","author":"Salinaro","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1224578\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T21:44:32Z","timestamp":1692308672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1224578\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":56,"alternative-id":["10.3389\/fcvm.2023.1224578"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1224578","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"article-number":"1224578"}}